These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 25272944)

  • 21. Enhanced cardioprotection against ischemia-reperfusion injury with combining sildenafil with low-dose atorvastatin.
    Rosanio S; Ye Y; Atar S; Rahman AM; Freeberg SY; Huang MH; Uretsky BF; Birnbaum Y
    Cardiovasc Drugs Ther; 2006 Feb; 20(1):27-36. PubMed ID: 16435070
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rosuvastatin given during reperfusion decreases infarct size and inhibits matrix metalloproteinase-2 activity in normocholesterolemic and hypercholesterolemic rabbits.
    D'Annunzio V; Donato M; Erni L; Miksztowicz V; Buchholz B; Carrión CL; Schreier L; Wikinski R; Gelpi RJ; Berg G; Basso N
    J Cardiovasc Pharmacol; 2009 Feb; 53(2):137-44. PubMed ID: 19188835
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardioprotection of CAPE-oNO
    Li D; Wang X; Huang Q; Li S; Zhou Y; Li Z
    Redox Biol; 2018 May; 15():62-73. PubMed ID: 29220696
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rosuvastatin reduces rat intestinal ischemia-reperfusion injury associated with the preservation of endothelial nitric oxide synthase protein.
    Naito Y; Katada K; Takagi T; Tsuboi H; Kuroda M; Handa O; Kokura S; Yoshida N; Ichikawa H; Yoshikawa T
    World J Gastroenterol; 2006 Apr; 12(13):2024-30. PubMed ID: 16610051
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preconditioning with acute and chronic lithium administration reduces ischemia/reperfusion injury mediated by cyclooxygenase not nitric oxide synthase pathway in isolated rat heart.
    Faghihi M; Mirershadi F; Dehpour AR; Bazargan M
    Eur J Pharmacol; 2008 Nov; 597(1-3):57-63. PubMed ID: 18789320
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Statins and the response to myocardial injury.
    Scalia R
    Am J Cardiovasc Drugs; 2005; 5(3):163-70. PubMed ID: 15901204
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rosuvastatin preconditioning provides neuroprotection against spinal cord ischemia in rats through modulating nitric oxide synthase expressions.
    Die J; Wang K; Fan L; Jiang Y; Shi Z
    Brain Res; 2010 Jul; 1346():251-61. PubMed ID: 20513366
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rosuvastatin, a new HMG-CoA reductase inhibitor, upregulates endothelial nitric oxide synthase and protects from ischemic stroke in mice.
    Laufs U; Gertz K; Dirnagl U; Böhm M; Nickenig G; Endres M
    Brain Res; 2002 Jun; 942(1-2):23-30. PubMed ID: 12031849
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A treatment with rosuvastatin induced a reduction of arterial pressure and a decrease of oxidative stress in spontaneously hypertensive rats].
    Sicard P; Lauzier B; Oudot A; Busseuil D; Collin B; Duvillard L; Moreau D; Vergely C; Rochette L
    Arch Mal Coeur Vaiss; 2005; 98(7-8):804-8. PubMed ID: 16220751
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protective Effects of Shenfu Injection against Myocardial Ischemia-Reperfusion Injury via Activation of eNOS in Rats.
    Wang YY; Li YY; Li L; Yang DL; Zhou K; Li YH
    Biol Pharm Bull; 2018 Sep; 41(9):1406-1413. PubMed ID: 29910216
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adiponectin protects against myocardial ischaemia-reperfusion injury via AMP-activated protein kinase, Akt, and nitric oxide.
    Gonon AT; Widegren U; Bulhak A; Salehzadeh F; Persson J; Sjöquist PO; Pernow J
    Cardiovasc Res; 2008 Apr; 78(1):116-22. PubMed ID: 18222959
    [TBL] [Abstract][Full Text] [Related]  

  • 32. eNOS/Hsp70 interaction on rosuvastatin cytoprotective effect in neonatal obstructive nephropathy.
    Manucha W; Kurbán F; Mazzei L; Benardón ME; Bocanegra V; Tosi MR; Vallés P
    Eur J Pharmacol; 2011 Jan; 650(2-3):487-95. PubMed ID: 20940012
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intravenous rosuvastatin for acute stroke treatment: an animal study.
    Prinz V; Laufs U; Gertz K; Kronenberg G; Balkaya M; Leithner C; Lindauer U; Endres M
    Stroke; 2008 Feb; 39(2):433-8. PubMed ID: 18162625
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protection against myocardial ischaemia/reperfusion injury by PPAR-alpha activation is related to production of nitric oxide and endothelin-1.
    Bulhak AA; Sjöquist PO; Xu CB; Edvinsson L; Pernow J
    Basic Res Cardiol; 2006 May; 101(3):244-52. PubMed ID: 16411023
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improved cardiac performance by rosuvastatin is associated with attenuations in both myocardial tumor necrosis factor-alpha and p38 MAP kinase activity in rats after myocardial infarction.
    Xu Y; Tang T; Ding Y; Yao R; Xie J; Liao M; Xiao H; Chen Y; Yu X; Fu M; Liao Y; Zhao G; Cheng X
    Am J Med Sci; 2010 Aug; 340(2):121-7. PubMed ID: 20588182
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HMG-CoA reductase inhibitor improves endothelial dysfunction in spontaneous hypertensive rats via down-regulation of caveolin-1 and activation of endothelial nitric oxide synthase.
    Suh JW; Choi DJ; Chang HJ; Cho YS; Youn TJ; Chae IH; Kim KI; Kim CH; Kim HS; Oh BH; Park YB
    J Korean Med Sci; 2010 Jan; 25(1):16-23. PubMed ID: 20052342
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A new HMG-CoA reductase inhibitor, rosuvastatin, exerts anti-inflammatory effects on the microvascular endothelium: the role of mevalonic acid.
    Stalker TJ; Lefer AM; Scalia R
    Br J Pharmacol; 2001 Jun; 133(3):406-12. PubMed ID: 11375257
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of bradykinin and nitric oxide in the cardioprotective action of ACE inhibitors.
    Hartman JC
    Ann Thorac Surg; 1995 Sep; 60(3):789-92. PubMed ID: 7545893
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aggravation of focal cerebral ischemia by tissue plasminogen activator is reversed by 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor but does not depend on endothelial NO synthase.
    Kilic E; Kilic U; Matter CM; Lüscher TF; Bassetti CL; Hermann DM
    Stroke; 2005 Feb; 36(2):332-6. PubMed ID: 15625301
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Attenuation of monocrotaline-induced pulmonary arterial hypertension in rats by rosuvastatin.
    Li XL; Guan RJ; Li JJ
    J Cardiovasc Pharmacol; 2012 Aug; 60(2):219-26. PubMed ID: 22592772
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.